Gemcitabine Exposure Induces Epigenomic Remodeling in Pancreatic Cancer Cells during Resistance Development

被引：0
|
作者：
Urrutia, Guillermo [1 ]
Dusetti, Nelson [2 ]
Iovanna, Juan [2 ]
Urrutia, Raul [1 ]
Lomberk, Gwen [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI USA
[2] Ctr Rech Cancerol Marseille, Marseille, France
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.05341
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identification of Novel Biomarkers for Gemcitabine Resistance in Pancreatic Cancer
    Jeong, Eun-Jeong
    Han, Tae-Su
    Kim, Jang-Seong
    CANCER SCIENCE, 2018, 109 : 1385 - 1385
  • [42] Erratum to: Clusterin confers gemcitabine resistance in pancreatic cancer
    Qingfeng Chen
    Zhengkun Wang
    Kejun Zhang
    Xiaoyi Liu
    Weihong Cao
    Lei Zhang
    Shuhua Zhang
    Bomin Yan
    Yaoguang Wang
    Chunping Xia
    World Journal of Surgical Oncology, 11
  • [43] Prediction of gemcitabine resistance in patients with pancreatic cancer.
    Nakahira, S.
    Nakamori, S.
    Tsujie, M.
    Okami, J.
    Takemasa, I.
    Takeda, Y.
    Nagano, H.
    Dono, K.
    Sakon, M.
    Monden, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 209S - 209S
  • [44] Identification of novel drivers of gemcitabine resistance in pancreatic cancer
    Bilalbegovic, Amina D.
    Fu, Bowen
    Nwosu, Zeribe
    CANCER RESEARCH, 2024, 84 (17)
  • [45] Gemcitabine resistance in pancreatic cancer: Picking the key players
    Kim, Michael P.
    Gallick, Gary E.
    CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1284 - 1285
  • [46] ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
    Zheng, Chunning
    Jiao, Xuelong
    Jiang, Yingsheng
    Sun, Shaochuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (02) : 300 - 306
  • [47] BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis
    Wang, Weiming
    Zhou, Xiang
    Kong, Lingming
    Pan, Zhenyan
    Chen, Gang
    CANCERS, 2024, 16 (08)
  • [48] Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells
    Li, Fu
    Hu, Gang
    Jiang, Zhenzhou
    Guo, Jingjing
    Wang, Ke
    Ouyang, Kedong
    Wen, Danyi
    Zhu, Minghua
    Liang, Jiaxin
    Qin, Xiaoran
    Zhang, Luyong
    FEBS JOURNAL, 2012, 279 (07) : 1261 - 1273
  • [49] Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer
    Liu, Yang
    Li, Fan
    Gao, Feng
    Xing, Lingxi
    Qin, Peng
    Liang, Xingxin
    Zhang, Jiajie
    Qiao, Xiaohui
    Lin, Lizhou
    Zhao, Qian
    Du, Lianfang
    TUMOR BIOLOGY, 2016, 37 (11) : 15283 - 15291
  • [50] The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer
    Chiu, Ching-Feng
    Lin, Hui-Ru
    Su, Yen-Hao
    Chen, Hsin-An
    Hung, Shao-Wen
    Huang, Shih-Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
12345